Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nudge, nudge: simple texts could curb diabetes epidemic

NCT ID NCT04869917

First seen Nov 06, 2025 · Last updated Jun 23, 2026 · Updated 27 times

Summary

This study tests whether easy-to-use tools like a decision aid and text messages can encourage people with prediabetes to take proven steps—like joining a lifestyle program or taking metformin—to prevent type 2 diabetes. Nearly 1,000 adults from primary care clinics are taking part. The goal is to find practical, low-cost ways to make diabetes prevention a routine part of healthcare.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Northwestern University

    Chicago, Illinois, 60611, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

behavioral nudges (decision aid and text messaging)

What this could lead to

If successful, this could provide a low-cost, scalable way to help millions of people with prediabetes prevent or delay type 2 diabetes.

What could go wrong

The nudges are simple and may not be strong enough to change behavior in many people. The trial is also still ongoing, so results are not yet final.

Conditions

The condition(s) this trial relates to.

prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.